/PRNewswire/ The National Comprehensive Cancer Network® (NCCN®) an alliance of leading cancer centers today announced the publication of new NCCN Clinical.
The National Comprehensive Cancer Network publishes two new NCCN Guidelines for Malignant Peritoneal Mesothelioma and for Ampullary Adenocarcinoma, to standardize treatment and improve outcomes
The National Comprehensive Cancer Network publishes two new NCCN Guidelines for Malignant Peritoneal Mesothelioma and for Ampullary Adenocarcinoma, to standardize treatment and improve outcomes for these rare tumor types; also reaches milestone expanding library of NCCN Chemotherapy Order Templates. PLYMOUTH MEETING, Pa., March 9, 2022 /PRNewswire/ The National Comprehensive Cancer Network® (NCCN®) an alliance of leading cancer centers today.